CLINICAL ASPECTS OF GLYCEMIC MONITORING AND CONTOL IN PATIENTS IN THE EARLY POSTOPERATIVE PERIOD

Anesteziol Reanimatol. 2017 Jan;62(1):69-73.
[Article in English, Russian]

Abstract

Introduction: At present, no doubt enhanced by the attention of clinicians to monitor blood glucose and methods of its correction in ICU patients. Evidence of the effect of the expressed glycemic balance disorders on the results of treatment of such patients determine of the problem. Attempts to create a computer algorithm to determine the rate of insulin. The aim of the study was to investigate the efficacy and safety of the module Space glycemic control (SGC, "BBraun Germany) with intravenous insulin therapy in patients with thoracoabdominal surgery.

Material and methods: Single-center prospective observational study was conducted in the ICU in 50 patients in the early period after operations on the abdominal and thoracic cavity, mediastinum.

Results: The average duration of the monitoring group with SGC was 57 hours (17 to 280 hours). The average length of the period during which the patients were recorded in the target range glycemia was 80.4% of the total time of SGC monitoring. The average value of glucose in capillary blood proved to 7,6?1,58 mmol/l. The incidence of severe hypoglycemia was 2% (1 patient).

Conclusion: Application module SGC should expedient be used in patients after extensive thoracoabdiminal surgical procedures in which recorded postoperative hyperglycemia.

MeSH terms

  • Algorithms
  • Blood Glucose / analysis*
  • Drug Therapy, Computer-Assisted / methods*
  • Female
  • Humans
  • Hyperglycemia / diagnosis
  • Hyperglycemia / prevention & control*
  • Hypoglycemic Agents / administration & dosage
  • Hypoglycemic Agents / therapeutic use
  • Infusions, Intravenous
  • Insulin / administration & dosage
  • Insulin / therapeutic use
  • Intensive Care Units
  • Male
  • Middle Aged
  • Monitoring, Physiologic / methods*
  • Nutritional Support / methods*
  • Postoperative Care / methods*
  • Postoperative Period
  • Prospective Studies

Substances

  • Blood Glucose
  • Hypoglycemic Agents
  • Insulin